Introduction Liver resection carries a high risk for extensive bleeding and need for blood
transfusions, which is associated with significant negative impact on outcome. In malignant …

Introduction Liver resection carries a high risk for extensive bleeding and need for blood
transfusions, which is associated with significant negative impact on outcome. In malignant …

Introduction Liver disease causes 2 million deaths annually, accounting for 4% of all deaths
worldwide. Liver surgery is one of the effective therapeutic options. Bleeding is a major …

Background Elevated portal pressure in response to major liver resection is associated with
impaired liver regeneration and increased postoperative complications. Terlipressin, a …

Background Blood loss and perioperative blood transfusion requirements affect the long‐
term survival after liver resection for malignant tumours. Terlipressin is a synthetic …

Background Terlipressin, in general, is a vasopressor which acts via V1 receptors. Its
infusion elevates mean blood pressure and can reduce bleeding which has a splanchnic …

Materials and Methods A multiple-center, double-blind clinical trial was conducted; patients
who underwent gastrointestinal surgery were recruited from three hospitals and were …

We systematically reviewed the literature to investigate the effects of peri-procedural
desmopressin in patients without known inherited bleeding disorders undergoing surgery or …

Introduction Despite use of operative and non-operative interventions to reduce blood loss
during liver resection, 20%–40% of patients receive a perioperative blood transfusion …

Background Vascular occlusion used during elective liver resection to reduce blood loss
results in significant ischaemia reperfusion (IR) injury. This in turn leads to significant …